Identification and validation of PSMB7 as a novel biomarker for prognosis and immune infiltrates of lung adenocarcinoma
We identified PSMB7 as a promising biomarker for LUAD prognosis because of its strong association with tumor progression and immune microenvironment modulation. Future studies should explore therapeutic strategies targeting PSMB7 to improve patient outcomes for LUAD.
Authors
- Jie Ao
- Guihua Zhu (ORCID: https://orcid.org/0000-0003-4846-0914)
- Xin Ran (ORCID: https://orcid.org/0000-0001-9593-2748)
- Lianhua Zhao (ORCID: https://orcid.org/0000-0001-7178-3661)
- Yan Chen (ORCID: https://orcid.org/0000-0002-2423-7104)
- Hualiang Xiao (ORCID: https://orcid.org/0000-0001-7960-5536)
- Ping Fu (ORCID: https://orcid.org/0009-0006-4457-9079)
Institutions
- Army Medical University (CN)
- Daping Hospital (CN)
- Police General Hospital (TH)
Publication Details
- Journal
- PeerJ
- Published
- 2025-08-29
- DOI
- https://doi.org/10.7717/peerj.19958
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00